InsidersTradesSigma
申报总数
公司
▲ 买入（3 笔）
▼ 卖出（0 笔）
内部人交易记录
首席财务官已披露买入
3
已披露卖出
0
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Discover the detailed record of transactions filed by Vincent Richard G, 首席财务官. Director active across 1 company, notably Oncternal Therapeutics, Inc.. In total, 8 filings have been published. Split: 3 buys · 0 sell. Total volume traded: €16k. Activity tracked since 3 January 2022. The latest transaction was disclosed on 3 January 2024 (Retenue fiscale). Regulator: SEC (Form 4). All data is openly available.
Companies and markets linked to Vincent Richard G
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报8 总计
8,868 股@ US$0.496111.6% 占其流量Common StockSEC:0001209191-24-000972:0
7,069 股@ US$0.366.7% 占其流量Common StockSEC:0001209191-23-041316:0
30,000 股@ US$0.298723.4% 占其流量Common StockSEC:0001209191-23-024263:0
标准退出：2023年7月12日 (T+90)
4,428 股@ US$1.0212.2% 占其流量Common StockSEC:0001209191-23-002028:0
43,125 股0Common StockSEC:0001209191-22-043736:0
3 股@ US$1.450.0% 占其流量Common StockSEC:0001209191-22-021302:0
标准退出：2022年6月22日 (T+90)
5,000 股@ US$1.8030.0% 占其流量Common StockSEC:0001209191-22-005559:0
标准退出：2022年4月27日 (T+90)
29,867 股0Common StockSEC:0001209191-22-001971:0
8 条申报中的 8 条
About Vincent Richard G
VINCENT RICHARD G is Directeur Financier and Chief Financial Officer at Oncternal Therapeutics, Inc. He has 8 filings in total, and across the 8 sampled recent filings, buys total 16115 EUR and sells total 0 EUR, with activity from 2022-01-05 to 2024-01-05. The most common transaction nature is Tax withholding.
